Monocarboxylate Transporter 5, Human (MCT5) (Control Peptide)

Catalog No : USB-M4470-40B
417.25€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Monocarboxylate Transporter 5, Human (MCT5) (Control Peptide)
Catalog No USB-M4470-40B
Supplier’s Catalog No M4470-40B
Supplier US Biologicals
Source antigen Human synthetic peptide
Reactivity 64% conserved in mouse. No significant sequence homology exists with other MCTs. Control peptide, because of its low MW (<3kD), is not suitable for Western. It should be used for ELISA or antibody blocking (use 5-10 ug per 1 ul of antiserum or 1 ug of aff pure IgG) to confirm antibody specificity.
Cross reactivity
Applications
Molecular weight
Storage -20°C
Other names
Grade Highly Purified
Purity Highly purified
Form Supplied as a liquid in PBS, pH 7.2
Reactivity life 12 months
Note For reserch purpose only
Purity Highly purified
Description A 19-aa peptide sequence within the Cytoplasmic loop # 4 of human MCT5. Monocarboxylate such as lactate and pyruvate play an important role in cellular metabolism. Lactic acid is produced as the end product of glycolysis. Some tissues, such as white skeletal muscle and, red blood cells, use this pathway to generate most of their ATP under normal physiological conditions. All tissues become dependent on this pathway during abnormal conditions such as hypoxia and ischaemia. Lactic acid, produced during normal glycolysis, must be transported out of cells to sustain maintain high rate of glycolysis. Failure to export lactic acid leads to accumulation of cellular lactic acid followed by an increase in pH and inhibition of glycolysis. Some tissues, such as brain, heart, and red skeletal muscle, readily oxidize lactic acid, and must import lactic acid into the cells. Lactic acid transport is mediated by a group of proton-linked membrane transporters called monocarboxylic acid transporters (MCTs). At least 9 MCT-related proteins (MCT1-9) have been identified in mammals that are expressed in a tissue specific manner. MCT5/SLC16A4 (mouse 468-aa, human 487-aa, chromosome 1p13.1) shares 25% sequence homology with MCT1, but it has much shorter C-terminus than other MCTs. MCT5 has an Alu insertion even in the 3'-UTR and a truncated C-terminus. High expression of MCT5 has been observed in placenta. According to new nomenclature, the old MCT4 has now been reclassified as MCT5. This antibody has previously been listed as MCT42-S. Please consult the main MCT page for details on the new nomenclature.